skip to main content

Naloxone and opioid safety — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

ModerateCNS TherapeuticsNaloxone and opioid safetyGPhC CRA

A patient collects oxycodone modified-release for chronic non-cancer pain after a recent dose increase. His partner says he has been very sleepy and occasionally difficult to rouse. He also takes diazepam at night. What is the most appropriate action?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: EAdvise urgent clinical review because opioid toxicity risk is possible

Excessive sedation and difficulty rousing may indicate opioid toxicity, especially after dose escalation and with benzodiazepine co-use. This can progress to respiratory depression. Modified-release tablets must not be crushed, and urgent prescriber or emergency advice is needed depending on severity.

Reference: BNF; NICE CKS